Dragon Fruit | 24.52mg Per Tablet

Alkaloid Profile (Per Tablet)

Total Alkaloid Content: 24.52 mg

7-Hydroxymitragynine: 98.90% (24.25mg)

Mitragynine Pseudoindoxyl: 1.10% (0.27mg)

Packaging Information

Packaging: Light purple mylar

Single Pack: 5 tablets per pack

Multipack: 50 tablets per pack

Product Description

Dragon Fruit Ember is a refined, Thai-style tablet designed for users who value balance, smoothness, and controlled delivery over sheer intensity. Built around a clean, calibrated alkaloid profile, this formulation emphasizes stability, clarity, and consistency while maintaining enough strength to satisfy experienced users.

Driven primarily by 7-Hydroxymitragynine, Dragon Fruit Ember delivers a gentle but confident onset that builds evenly and remains centered throughout the experience. A minimal inclusion of Mitragynine Pseudoindoxyl supports structure and duration without introducing volatility, resulting in a composed, steady profile with no sharp peaks or abrupt drop-off.

Pressed using traditional Thai-style techniques, Dragon Fruit Ember favors gradual development and control. It is well-suited for users seeking reliable performance for focus, creativity, or sustained relief without the aggressive intensity found in higher-tier formulations.

Caution & Responsible Use

This product is intended for users with prior experience. While lower in total alkaloid content than ultra-high-strength offerings, Dragon Fruit Ember still contains a potent concentration and should be approached with care. Start with a small amount, allow sufficient time to fully assess effects, and avoid rapid redosing. Responsible, measured use is strongly recommended.

This product is not available for shipment to the following states: Alabama, Arkansas, Indiana, Rhode Island, Wisconsin, Florida; or the following counties: San Diego (California), Oceanside (California), Alton (Illinois), Jerseyville (Illinois), Edwardsville County (Illinois), Columbus (Mississippi), Union County (Mississippi), Ascension (Louisiana), Franklin (Louisiana), Ohio, and Rapides (Louisiana).

FDA Disclaimer:

The statements made regarding these products have not been evaluated by the Food and Drug Administration. The efficacy of these products has not been confirmed by FDA-approved research. These products are not intended to diagnose, treat, cure, or prevent any disease.

Kratom products have not been evaluated or approved by the U.S. Food and Drug Administration (FDA) for safety, effectiveness, or as a treatment for any medical condition. The information provided on this website is for educational purposes only and should not be construed as medical advice. Kratom is not intended to diagnose, treat, cure, or prevent any disease.